세계의 세포배양 보충제 시장 보고서(2025년)
Cell Culture Supplements Global Market Report 2025
상품코드 : 1889330
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,505,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,403,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,301,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세포배양 보충제 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2024년 36억 달러로 평가되었고, 2025년에는 39억 6,000만 달러에 달할 것으로 추정되며, CAGR 9.9%로 확대될 전망입니다. 지난 수년간의 성장은 재생의료에 대한 수요 증가, 줄기세포 연구의 보급 확대, 바이오의약품 생산 확대, 세포 배양 배지의 기술 진보, 학술 및 임상 조사의 성장에 기인하는 것으로 보입니다.

세포배양 보충제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 57억 달러에 달할 것으로 예측되며, CAGR 9.6%로 성장할 전망입니다. 예측 기간의 성장요인으로는 유전자 및 세포 치료에 대한 투자 증가, 맞춤형 의료 수요 증가, 생물학적 제제 제조 확대, 3D 세포배양 시스템의 기술 진보, 생명과학 연구에 대한 정부 자금 증가 등이 있습니다. 예측 기간 동안 예상되는 주요 동향으로는 무혈청 화학적으로 정의된 배지로의 전환, 세포배양 워크플로우에서의 자동화 통합 확대, 3D 모델 및 오가노이드 모델의 보급 확대, 특수한 성장 인자의 개발, 재현성과 하이 스루풋 스크리닝에 대한 더욱 중점화 등을 들 수 있습니다.

재생 의료에 대한 관심 증가는 향후 수년간 세포배양 보충제 시장의 성장을 이끌 것으로 예측됩니다. 재생 의료는 손상된 세포, 조직, 장기를 복구, 대체, 재생하여 정상적인 기능을 회복시키는 것을 목적으로 한 학제적인 분야입니다. 줄기세포 연구, 유전자 치료, 조직 공학에 대한 정부 및 민간 부문의 투자 증가는 이 분야에 대한 주력을 뒷받침하고 있습니다. 세포배양 보충제는 재생의료 연구 및 치료법 개발에 필요한 다양한 세포종의 배양 및 유지에 필수적입니다. 예를 들어, 2023년 7월에 미국 유전자 및 세포 치료 학회(ASGCT)가 보고한 바에 의하면, 2상 임상시험 단계에 있는 유전자 치료 수는 2023년 1분기 말의 247건에서 2분기 말에는 260건으로 증가했으며, 재생 의료 분야에서 활동의 활성화를 나타내고 있습니다. 이러한 연구 개발의 급증이 세포배양 보충제 수요를 직접적으로 밀어 올리고 있습니다.

시장의 주요 기업은 천연 조직 구조를 충실히 모방한 생리적으로 관련성이 높은 환경을 제공하는 비계 기반 3D 세포배양 시스템으로 혁신을 진행하고 있습니다. 이 시스템은 약물 스크리닝 정확도, 질병 모델링 및 치료 결과 예측을 향상시킵니다. 예를 들어, 2024년 7월에는 Bioserve India사가 iPS 세포와 ES세포를 이용한 줄기세포 배양, 분화, 질환 모델화를 위한 고급 줄기세포 제품군을 발표했습니다. 여기에는 특수 배양 배지, 성장 인자, 스캐폴드 기반 3D 시스템 및 세포 분석이 포함됩니다. 이 회사의 포트폴리오에는 인간 조직 기술을 이용한 전임상 서비스와 60만점 이상의 생체 시료를 보유한 세계적인 바이오 리포지토리도 포함되어 있으며 연구 개발을 모두 지원하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Cell culture supplements are specialized formulations that enhance the growth, viability, and productivity of cells in controlled environments. They supply essential nutrients, growth factors, and signaling molecules that support optimal cellular function. These supplements improve consistency and reproducibility in cell culture processes, enabling efficient, reliable outcomes and accelerating both experimental and production timelines.

The primary product types of cell culture supplements include growth factors and cytokines, amino acids, vitamins, hormones, attachment factors, and others. Growth factors and cytokines are biologically active proteins that regulate cell growth, differentiation, and signaling in vitro to support the development of cell cultures. These supplements are derived from various sources, including animal-based, human-based, synthetic, and plant-based materials, and are used across multiple applications such as biopharmaceutical production, tissue engineering and regenerative medicine, diagnostics, drug development, and more. Key end users include pharmaceutical and biotechnology companies, academic and research institutes, and other organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The cell culture supplements market research report is one of a series of new reports from The Business Research Company that provides cell culture supplements market statistics, including cell culture supplements industry global market size, regional shares, competitors with a cell culture supplements market share, detailed cell culture supplements market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture supplements industry. The cell culture supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell culture supplements market size has grown strongly in recent years. It will grow from $3.60 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. Growth during the historic period can be attributed to rising demand for regenerative medicine, increased adoption of stem cell research, expansion of biopharmaceutical production, advancements in cell culture media, and the growth of academic and clinical research.

The cell culture supplements market size is expected to see strong growth in the next few years. It will grow to $5.70 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. Growth in the forecast period can be attributed to increasing investment in gene and cell therapy, rising demand for personalized medicine, expansion of biologics manufacturing, technological progress in 3D cell culture systems, and greater government funding for life sciences research. Major trends expected in the forecast period include a shift toward serum-free and chemically defined media, increased integration of automation in cell culture workflows, broader adoption of 3D and organoid models, development of specialized growth factors, and a stronger emphasis on reproducibility and high-throughput screening.

The increasing focus on regenerative medicine is expected to drive growth in the cell culture supplements market in the coming years. Regenerative medicine is an interdisciplinary field that aims to repair, replace, or regenerate damaged cells, tissues, and organs to restore normal function. Rising investments from governments and private sectors in stem cell research, gene therapies, and tissue engineering are fueling this focus. Cell culture supplements are essential for cultivating and maintaining the diverse cell types required in regenerative medicine research and therapy development. For example, in July 2023, the American Society of Gene & Cell Therapy (ASGCT) reported that the number of gene therapies in Phase II trials increased from 247 at the end of Q1 2023 to 260 by the end of Q2 2023, illustrating the growing activity in regenerative medicine. This surge in research and therapeutic development is directly boosting demand for cell culture supplements.

Key players in the market are innovating with scaffold-based 3D cell culture systems, which provide physiologically relevant environments that closely mimic natural tissue architecture. These systems improve drug screening accuracy, disease modeling, and prediction of therapeutic outcomes. For instance, in July 2024, Bioserve India launched advanced stem cell products featuring specialized culture media, growth factors, scaffold-based 3D systems, and cellular assays for stem cell culture, differentiation, and disease modeling using iPSCs and ESCs. The portfolio also includes preclinical services using human tissue technology and a global biorepository with over 600,000 biospecimens, supporting both research and therapy development.

In May 2025, PL BioScience, a Germany-based life sciences company, partnered with DewCell Biotherapeutics of South Korea to advance fully animal-free, high-performance cell culture supplements. This collaboration focuses on developing synthetic human platelet lysate (HPL) media, providing scalable, ethical, and regulatory-compliant solutions for cell therapy and biopharmaceutical production. These innovations reinforce the market's growth by supporting safer, more reproducible, and scalable cell culture processes for regenerative medicine.

Major companies operating in the cell culture supplements market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare, Corning Incorporated, Lonza Group AG, Sartorius AG, Bio-Techne Corporation, Repligen Corporation, Takara Bio Inc., HiMedia Laboratories, PromoCell GmbH, RoosterBio Inc., Capricorn Scientific GmbH, Genexis Biotech Pvt Ltd., PromoKine GmbH, BioProcess Technologies Ltd., Jin Kairui Biotechnology Co. Ltd., FUJIFILM Irvine Scientific, Athena Enzyme Systems.

North America was the largest region in the cell culture supplements market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell culture supplements report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell culture supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell culture supplements market consists of sales of fetal bovine serum, human serum, extracellular matrix proteins, and supplements for differentiation. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Culture Supplements Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell culture supplements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cell culture supplements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell culture supplements market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Cell Culture Supplements Market Characteristics

3. Cell Culture Supplements Market Trends And Strategies

4. Cell Culture Supplements Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cell Culture Supplements Growth Analysis And Strategic Analysis Framework

6. Cell Culture Supplements Market Segmentation

7. Cell Culture Supplements Market Regional And Country Analysis

8. Asia-Pacific Cell Culture Supplements Market

9. China Cell Culture Supplements Market

10. India Cell Culture Supplements Market

11. Japan Cell Culture Supplements Market

12. Australia Cell Culture Supplements Market

13. Indonesia Cell Culture Supplements Market

14. South Korea Cell Culture Supplements Market

15. Western Europe Cell Culture Supplements Market

16. UK Cell Culture Supplements Market

17. Germany Cell Culture Supplements Market

18. France Cell Culture Supplements Market

19. Italy Cell Culture Supplements Market

20. Spain Cell Culture Supplements Market

21. Eastern Europe Cell Culture Supplements Market

22. Russia Cell Culture Supplements Market

23. North America Cell Culture Supplements Market

24. USA Cell Culture Supplements Market

25. Canada Cell Culture Supplements Market

26. South America Cell Culture Supplements Market

27. Brazil Cell Culture Supplements Market

28. Middle East Cell Culture Supplements Market

29. Africa Cell Culture Supplements Market

30. Cell Culture Supplements Market Competitive Landscape And Company Profiles

31. Cell Culture Supplements Market Other Major And Innovative Companies

32. Global Cell Culture Supplements Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Culture Supplements Market

34. Recent Developments In The Cell Culture Supplements Market

35. Cell Culture Supplements Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기